伤科益肾壮骨丸调控Hippo-YAP/TAZ通路对膝骨关节炎大鼠软骨的影响OA
Effects of Shangke Yishen Zhuanggu Pills on Cartilage in Rats with Knee Osteoarthritis via Regulation of the Hippo-YAP/TAZ Pathway
目的 探讨伤科益肾壮骨丸调节 Hippo-Yes 相关蛋白(YAP)/PDZ 结合转录共激活因子(TAZ)通路对膝骨关节炎(KOA)大鼠软骨形态的影响.方法 将 SD 大鼠随机分为假手术组、模型组、模型+伤科益肾壮骨丸(0.5 g·kg-1)组、模型+伤科益肾壮骨丸+si-NC 组和模型+伤科益肾壮骨丸+si-LATS 组,每组 8 只大鼠.进行大鼠膝骨关节软骨形态观察;番红 O-固绿染色观察膝骨关节软骨组织形态;TUNEL 实验检测软骨细胞凋亡情况;免疫组织化学染色检测 p-YAP1 表达情况;Western Blot 实验检测细胞外基质和 Hippo-YAP/TAZ 通路相关蛋白表达.结果 与假手术组比较,模型组膝骨关节软骨呈浅黄色,关节面粗糙,出现溃烂斑点和骨赘,软骨组织中番红 O 淡染,TUNEL 阳性率和 MMP13 表达明显升高(P<0.05),聚集蛋白聚糖(ACAN)、抗体Ⅱ型胶原 α1链(COL2A1)、p-大型肿瘤抑制激酶 1/2(p-LATS1/2)、p-YAP1 和 TAZ 表达明显降低(P<0.05);与模型组比较,模型+伤科益肾壮骨丸组及模型+伤科益肾壮骨丸+si-NC 组膝骨关节软骨呈乳白色,关节面光滑、无裂纹、无骨赘,软骨组织红染,TUNEL 阳性率和 MMP13 表达明显降低(P<0.05),ACAN、COL2A1、p-LATS1/2、p-YAP1 和 TAZ 表达明显升高(P<0.05),且模型+伤科益肾壮骨丸组与模型+伤科益肾壮骨丸+si-NC 组的差异无统计学意义(P>0.05);与模型+伤科益肾壮骨丸+si-NC 组比较,模型+伤科益肾壮骨丸+si-LATS 组膝骨关节软骨呈浅黄色,关节面粗糙、溃烂,番红 O 淡染,TUNEL 阳性率和 MMP13 表达明显升高(P<0.05),ACAN、COL2A1、p-LATS1/2、p-YAP1 和 TAZ 表达明显降低(P<0.05).结论 伤科益肾壮骨丸可能通过调控 Hippo-YAP/TAZ 通路中关键蛋白的表达,维持软骨正常形态和细胞外基质平衡,缓解膝骨关节炎大鼠膝骨关节软骨退化及损伤.
Objective To investigate the effects of Shangke Yishen Zhuanggu Pills on cartilage morphology in rats with knee osteoarthritis(KOA)by regulating the Hippo-YAP/TAZ pathway.Methods SD successfully modeled SD rats were divided into sham-operated group,model group,model+Shangke Yishen Zhuanggu Pills(0.5 g·kg-1)group,model+Shangke Yishen Zhuanggu Pills+si-NC group,and model+Shangke Yishen Zhuanggu Pills+si-LATS group,with 8 rats in each group.Morphological observation of rat knee articular cartilage was performed;Safranin O-Fast Green staining was used to observe the histomorphology of knee articular cartilage;TUNEL assay was conducted to detect chondrocyte apoptosis;immunohistochemical staining was performed to detect p-YAP1 expression;Western Blot was used to detect the expression of extracellular matrix and Hippo-YAP/TAZ pathway-related proteins.Results Compared with the sham-operated group,the knee articular cartilage in the model group appeared light yellow with a rough articular surface,ulcerated spots,and osteophytes;cartilage tissue showed pale Safranin O staining;the TUNEL-positive rate and MMP13 expression were significantly increased(P<0.05);while the expressions of Aggrecan(ACAN),Collagen type Ⅱ α1 chain(COL2A1),p-Large tumor suppressor kinase 1/2(p-LATS1/2),p-YAP1,and TAZ were significantly decreased(P<0.05).Compared with the model group,the knee articular cartilage in the model+Shangke Yishen Zhuanggu Pills group and the model+Shangke Yishen Zhuanggu Pills+si-NC group appeared milky white with a smooth articular surface,no cracks,and no osteophytes;cartilage tissue showed red staining;the TUNEL-positive rate and MMP13 expression were significantly decreased(P<0.05);while the expressions of ACAN,COL2A1,p-LATS1/2,p-YAP1,and TAZ were significantly increased(P<0.05);moreover,there was no statistically significant difference between the model+Shangke Yishen Zhuanggu Pills group and the model+Shangke Yishen Zhuanggu Pills+si-NC group(P>0.05).Compared with the model+Shangke Yishen Zhuanggu Pills+si-NC group,the knee articular cartilage in the model+Shangke Yishen Zhuanggu Pills+si-LATS group appeared light yellow with a rough,ulcerated articular surface;Safranin O staining was pale;the TUNEL-positive rate and MMP13 expression were significantly increased(P<0.05);while the expressions of ACAN,COL2A1,p-LATS1/2,p-YAP1,and TAZ were significantly decreased(P<0.05).Conclusion Shangke Yishen Zhuanggu Pills may alleviate knee articular cartilage degeneration and injury in rats with knee osteoarthritis by regulating the expression of key proteins in the Hippo-YAP/TAZ pathway,thereby maintaining normal cartilage morphology and extracellular matrix homeostasis.
蔡青;盛浩;黄宇玮;裴轩烨;许敏;张朝驹;涂杨茂;马晓飞;朱元元;胡杰;吴磊磊;余文举
湖北中医药大学附属荆州市中医医院骨科二病区,湖北 荆州 434000湖北中医药大学,湖北 武汉 430000湖北中医药大学,湖北 武汉 430000湖北中医药大学,湖北 武汉 430000荆州职业技术学院,湖北 荆州 434000湖北中医药大学附属荆州市中医医院骨科二病区,湖北 荆州 434000湖北中医药大学附属荆州市中医医院骨科二病区,湖北 荆州 434000湖北中医药大学附属荆州市中医医院骨科二病区,湖北 荆州 434000湖北中医药大学附属荆州市中医医院骨科二病区,湖北 荆州 434000湖北中医药大学附属荆州市中医医院骨科二病区,湖北 荆州 434000湖北中医药大学附属荆州市中医医院骨科二病区,湖北 荆州 434000湖北中医药大学附属荆州市中医医院骨科二病区,湖北 荆州 434000
医药卫生
膝骨关节炎软骨细胞伤科益肾壮骨丸Hippo-Yes相关蛋白/PDZ结合转录共激活因子通路大鼠
knee osteoarthritischondrocytesShangke Yishen Zhuanggu PillsHippo-YAP/TAZ pathwayrats
《中药新药与临床药理》 2026 (5)
828-835,8
湖北省自然科学基金项目(2024AFD348)湖北省时珍人才工程科研项目(鄂卫函[2024]256号)湖北省中医药管理局科研项目(ZY2025L015)荆州市科学技术局项目(2025HD131).
评论